Medindia
Advertisement

Discovery of Distinct Lung Cancer Pathways Lead to More Targeted Treatments: Study

by Iswarya on August 2, 2019 at 1:31 PM

Discovery of Distinct Lung Cancer Pathways Lead to More Targeted Treatments: Study

Identification of specific lung cancer pathway increases the ability to predict which patients are likely or unlikely to benefit from a particular treatment, reveals a new study. The findings of the study are published in the journal Cancer Cell.

Known for its poor prognosis, lung adenocarcinoma is the most common type of lung cancer, responsible for about 4 of 10 diagnoses, according to the National Cancer Institute. Researchers on Mayo Clinic's Florida campus can now distinguish between two pathways where this deadly cancer can develop. They say their discovery could help future patients.

Advertisement


"The ability to identify the specific pathway by which a patient's lung adenocarcinoma came about increases our ability to predict which patients are likely or unlikely to benefit from a particular treatment, and hopefully offer alternative options to patients whose cancer subtype is unlikely to respond," says Alan Fields, Ph.D., a cancer biologist and the study's senior author. Dr. Fields is the Monica Flynn Jacoby Professor of Cancer Research at Mayo Clinic.

He and his team studied the molecular features of lung adenocarcinoma in mice and found two ways that this cancer can develop. The first way depends on the cancer-causing gene known as "protein kinase C iota (PKCiota)." The second pathway, identified as the "Wnt/Beta-catenin signaling pathway," was found to operate independently of PKCiota. Lung adenocarcinomas that stem from the two different pathways were also found to form in different regions of the lung and through different cells of origin.
Advertisement

Once these two pathways were revealed in mice, Dr. Fields and colleagues considered how their discovery may apply to people. To begin, they compared the pathways in the mouse model to the six known molecular subtypes of this cancer in humans. The scientists found a match: a molecular marker that allowed them to predict which human lung adenocarcinoma cells originated from the PKCiota-independent pathway that they'd discovered in mice.

To test whether the tumors arising from the PKCiota-dependent and independent pathways might be sensitive to specific cancer therapies, Dr. Fields' team then conducted an experiment on human cells and the mouse model. As hypothesized, they found that two drugs affected the adenocarcinoma subtypes differently, depending on their underlying pathway. These results suggested to the investigators that they can predict how these cancer subtypes will respond to targeted therapies.

As a next step, the team will work to determine whether they can effectively and specifically identify PKCiota-dependent versus independent lung adenocarcinoma in human patients and confirm whether experimental drugs can predictably inhibit the growth of lung cancer in the PKCiota-dependent and independent patients.

Because the PKCiota pathway is also important to other cancers, the researchers think that their findings may apply beyond lung cancer.

This work builds on previous efforts by Dr. Fields and colleagues, who were the first to discover the connection between PKCiota, and the initiation, promotion and spread of lung cancers.

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
'Hybrid Immunity' may Help Elude COVID-19 Pandemic
Stroop Effect
Plant-Based Diet may Reduce the Risk of COVID-19
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Lung Biopsy Lung Cancer Cancer and Homeopathy Cancer Facts Asbestosis Cancer Tattoos A Body Art Pneumoconiosis Smoking among Women Silicosis 

Recommended Reading
Lung Cancer Screening
Lung cancer accounts for nearly 1.3 million deaths annually worldwide. Lung cancer screening can ......
Artificial Intelligence Detects Lung Cancer Before Radiologists
Artificial intelligence (AI)-based deep learning technology can detect lung cancer faster and more ....
Lung Cancer Awareness Month - Improving Lung Cancer Survival
Lung cancer awareness month is observed in November and aims to educate the general public about ......
Common Blood Pressure Tablets May Increase Risk of Lung Cancer
A common blood pressure drug belonging to the class angiotensin-converting enzyme inhibitors (ACEI) ...
Asbestosis
Asbestosis is a chronic inflammatory lung disease that occurs due to long term exposure to asbestos ...
Lung Biopsy
The procedure by which tissue samples are obtained from the lung is known as lung biopsy. The biopsy...
Lung Cancer
Lung cancer is a malignant tumor in the lung tissues. Smoking is the main cause of lung cancer with ...
Pneumoconiosis
Pneumoconiosis is a group of lung diseases caused by inhaled dust particles. It causes inflammation ...
Silicosis
Silicosis is a lung disease caused by inhalation of crystalline free silica dust. It is characterise...
Smoking among Women
Tobacco use in women is on the rise. The health risks of tobacco are far too many has never done a w...
Tattoos A Body Art
Tattoos are a rage among college students who sport it for the ‘cool dude’ or ‘cool babe’ look...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use